1519-GBM_H4512_Riboseq
SAMN33329333
External Id
dbGaP
INSDC center name
2023-02-16T22:15:29.750Z
INSDC first public
2023-12-20T22:05:16.587Z
INSDC last update
SRS17181006
INSDC secondary accession
live
INSDC status
Generic
NCBI submission model
Generic.1.0
NCBI submission package
SRS17181006
SRA accession
RNA
analyte type
NCI_NeoantigenCancerVaccine_GBM
biospecimen repository
GBM_H4512_Riboseq
biospecimen repository sample id
phs001519
gap_accession
2
gap_consent_code
HMB
gap_consent_short_name
5283870
gap_sample_id
4399383
gap_subject_id
Cultured primary cells
histological type
Yes
is tumor
Homo sapiens
http://purl.obolibrary.org/obo/NCBITaxon_9606
organism
male
sex
Clinical Trial
study design
Glioblastoma
study disease
A Phase I Study With a Personalized Neoantigen Cancer Vaccine in Glioblastoma Multiforme
study name
Yes
subject is affected
GBM_H4512_Riboseq
submitted sample id
GBM_H4512
submitted subject id
NCI_NeoantigenCancerVaccine_GBM
submitter handle
Glioblastoma tumor RNA sample from a human male participant in the dbGaP study A Phase I Study With a Personalized Neoantigen Cancer Vaccine in Glioblastoma Multiforme
title